Chen Hong, Wang Xie, Peng Nian, Pu Yue, Ye Hao, Gui Yu, Zhang Rui, Zhang Juan
Department of Neurology, The First Affiliated Hospital of Anhui University of Traditional Chinese Medicine, Hefei, 230031, People's Republic of China.
J Inflamm Res. 2024 Nov 25;17:9601-9616. doi: 10.2147/JIR.S489197. eCollection 2024.
Wilson's disease (WD) is a hereditary disorder characterized by an abnormality in copper metabolism. Liver fibrosis, and potentially cirrhosis, induced by copper accumulation are critical factors in the pathogenesis of WD. CircRNAs exhibit high stability and play crucial roles in numerous biological processes.
RNA-seq technology was employed to conduct transcriptome sequencing of the liver from 12 homozygous (TX) mice in the model group (NL group) and 12 wild-type (WT) mice in the control group (N group). Differentially expressed circular RNAs (DE-circRNAs) were identified, and following GO and KEGG analysis, a competitive endogenous RNA (ceRNA) regulatory network was constructed. The identified DE-circRNAs were then randomly validated using RT-qPCR.
Utilizing RNA sequencing (RNA-seq), the study identified 54 DE-circRNAs in TX-j mice with WD-induced liver fibrosis model, among which 19 were up-regulated and 35 were down-regulated. GO analysis revealed multiple biological processes, including single-organism process, cellular process, and metabolic process. Further pathway identification using KEGG implicated several pathways, including the HIF-1, PI3K-Akt, AMPK, FoxO, signaling pathway regulating pluripotency of stem cells, phospholipase D, mTOR, Ras, cGMP-PKG, and MAPK signaling pathway, among others. A ceRNA regulatory network was constructed with 20 circRNAs, 7 miRNAs, and 75 mRNAs as crucial core components. Additionally, RT-qPCR validation was performed on randomly selected DE-circRNAs, yielding consistent results (P<0.05).
The findings provide a significant molecular biology foundation for understanding the pathogenesis of liver fibrosis in WD and offer new insights for exploring potential diagnostic and therapeutic targets.
威尔逊病(WD)是一种遗传性疾病,其特征为铜代谢异常。铜蓄积诱导的肝纤维化以及潜在的肝硬化是WD发病机制中的关键因素。环状RNA(circRNA)具有高度稳定性,并在众多生物学过程中发挥关键作用。
采用RNA测序技术对模型组(NL组)12只纯合(TX)小鼠和对照组(N组)12只野生型(WT)小鼠的肝脏进行转录组测序。鉴定差异表达的环状RNA(DE-circRNA),并通过基因本体(GO)和京都基因与基因组百科全书(KEGG)分析构建竞争性内源性RNA(ceRNA)调控网络。然后使用逆转录定量聚合酶链反应(RT-qPCR)对鉴定出的DE-circRNA进行随机验证。
利用RNA测序(RNA-seq),该研究在WD诱导的肝纤维化模型TX-j小鼠中鉴定出54个DE-circRNA,其中19个上调,35个下调。GO分析揭示了多个生物学过程,包括单细胞过程、细胞过程和代谢过程。使用KEGG进行的进一步通路鉴定涉及多个通路,包括缺氧诱导因子-1(HIF-1)、磷脂酰肌醇-3激酶-蛋白激酶B(PI3K-Akt)、腺苷酸活化蛋白激酶(AMPK)、叉头框蛋白O(FoxO)、调节干细胞多能性的信号通路、磷脂酶D、哺乳动物雷帕霉素靶蛋白(mTOR)、Ras、环磷酸鸟苷-蛋白激酶G(cGMP-PKG)和丝裂原活化蛋白激酶(MAPK)信号通路等。构建了一个以20个circRNA、7个微小RNA(miRNA)和75个信使RNA(mRNA)为关键核心成分的ceRNA调控网络。此外,对随机选择的DE-circRNA进行RT-qPCR验证,结果一致(P<0.05)。
这些发现为理解WD肝纤维化的发病机制提供了重要的分子生物学基础,并为探索潜在的诊断和治疗靶点提供了新的见解。